Navigation Links
CVCTA Education Expands to Six New Campuses and Finalizes Acquisition Of CVI Training
Date:11/25/2008

lized its acquisition of CVI Training center of Columbia, South Carolina. "The acquisition of CVI reunited Dr. DeFrance and Dr. Newton and gave CVCTA Education a nationwide training presence. The combined efforts of CVCTA and CVI allow us to provide the highest quality training to the greatest number of physicians," said Dr. Dan Gebow, President of CVCTA. He also added, "Physicians who want to be trained in CTA have until July 2010 to complete their training before the grandfather clause ends and training becomes more time consuming. The CVI acquisition brings medical expertise, industry veterans, and a strong relationship with Tera Recon, positioning us well for the 18 month training window," said Dr. Gebow.

"With recent changes in healthcare reimbursement, being trained to a high level of expertise in CTA is more than meeting the guidelines for credentialing" said Dr. Tony DeFrance, "it is about physicians performing a comprehensive and accurate interpretation in a reasonable amount of time. It is about using the best technology and the best workflow." CVCTA's CTA training program emphasizes efficient workflow and a systematic reading method. To ensure the best technology is used by practicing physicians, CVCTA has partnered with Vital Images, Tera Recon, and Toshiba, who offer the most advanced technology in 3D advanced visualization.

About CVCTA Education:
CVCTA Education is a physician-owned and operated company dedicated to high quality education in the cardiac imaging field. CVCTA develops new educational, research and reporting tools that work to ensure responsible and efficient use of imaging technology. CVCTA Education is based in San Francisco, Californi
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CVCTA Education Announces New LOW DOSE Initiative for CT Angiograms
2. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
3. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
4. ADDAS Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them
5. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
6. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
7. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
8. Education Key Focus of Michigan Policy Summit
9. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
10. Study links education to risk of cancer death
11. Education Linked to Cancer Death Rates

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...ndCALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc....I)coilsandsoftwareandCalgaryScientificInc.,aleadin...ucedawebversionofAegis(TM)Breast4DAdvancedVisualiz...irsttrulyzero-footprintWebclientbasedmedicalimagin...)platformallowsforzero-footprintaccess-requiringno...
(Date:11/25/2009)...ISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManag...pare the Air Alert forThursday,November...anyothersolidfuel,bothindoorsandoutdoors. ,, "C...ytomorrow,"saidJackBroadbent,executiveofficerofthe...hehealthoftheirneighborsandfellowcommunitymemberst...
(Date:11/25/2009)...crease blood pressure? This simple question has b... New Stress-related gene Modulates High Blood Pres...essure? This simple question has been the focus o...ch has for the first time established a link betwe... response to stress in mice as well as humans. The...
(Date:11/25/2009)...plagued by neurological symptoms, study finds , ...Neurological side effects are among the potential ...r cancer who were treated with cisplatin-based che...ncluded 1,409 Norwegian men treated for unilateral...part in a follow-up survey conducted from 1998 to ...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...ern Medical College at Dallas report that contact ...xygen transmissible materials are expected to redu...han contact lenses which are available now. Based ...ar.// The results of the Southeastern study ar...
...he hair loss associated with drug treatment for ca...apy-induced alopecia (CIA), is a frequent side eff...g for patients at a vulnerable time in their lives...s with a skull cap to cool the scalp, minimising b...
...ion that is to blame for most panic attacks and ot...breakthrough could lead to the development of drug...ated that more than one in twelve people suffer fr...hobia. They found that 92% of the affected family ...
...rst clues to the high failure rate of cloning and ...ore of the nucleus.The discovery, announced at the...e Advancement of Science in Washington, shows that...ogether.// "Our genes are not uniformly distr...
...lder people avert a form of arthritis that can cha...lking an impossible one.Those who regularly walked...bilities to perform activities of daily living. ...elying on others for help// in these ordinary acti...
...screening technique for persons suffering from typ...rch Fund says investigations of skin lesions may a...rom a group of cancers, particularly those of the ...yposis colorectal cancer syndrome - it may be poss...
Other Medicine News:Health News:New contact lens materials 2Health News:Breakthrough in cancer therapy 2Health News:The anxiety gene, 2Health News:DNA and clones 2Health News:Arthritis risk reduced by exercise 2
(Date:11/25/2009)...25/PRNewswire-FirstCall/--HeskaCorporation(HSKA);(...specialtyproductstotheveterinaryindustry,announced...hesupplyofbloodgasproductsandaffiliatedconsumables...wscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ...efieldofadvancedpoint-of-carediagnostics,"commente...
(Date:11/25/2009)...Newswire/--BioTrendsResearchGroup,Inc.releasedWave...rstinamulti-phasesyndicatedmarketresearchprojecttr...omproductlaunchthroughthefirstsixmonthsofavailabil...tionfrom75uniqueDermatologistsandqualitativeinform...Stelara,obstaclestouse,typicalpatienttypes,product...
(Date:11/25/2009)...ov.25/PRNewswire/--RegadoBiosciences,aprivatelyhel...erswithactivecontrolagents,announcedthatDavidMazzo...fray21stAnnualHealthCareConferenceattheNewYorkPala...ivenat1:10pm(EST)onTuesday,December1andwillinclude...eaddevelopmentprogram,theanticoagulantsystem,REG1....
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 1Michael S Burg Appointed as Co Lead Counsel in the Yasmin Yaz Multidistrict Litigation 61325 2Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 1Esperion Therapeutics Initiates Phase I Clinical Study for ETC 1002 14833 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 1ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 2ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 3ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 4ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 5ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 6ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 7ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 8ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 9ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 10ReSearch Pharmaceutical Services Inc Unaudited Quarterly Report for the Period Ended September 30 2009 6258 11
...AM, England, October 7 ,Sosei Group Corporation ("... plc ("Vectura"; LSE: VEC), announce results of tw... and tolerability of NVA237 presented at the,annua...S) in Berlin,Germany. The new data show that NVA23...cting muscarinic antagonist (LAMA), provides susta...
...pens the door to the understanding of and possible... and cancer, BILLERICA, Mass., Oct. 6 Seahorse B... ever analytical instrument for the,kinetic measur...plasmic,glycolysis in cells in a 96 well microplat...lar bioenergetics have been relatively unchanged s...
Other Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3
STELLARA™
...m Thermo Labsystems was designed specifically to c... Advanced features such as the new fast dial syst...es help to define this as a new leader in single c...ate offers a custom fit for different hand sizes. ...
Corning Lambda Single Channel Pipettor, 0.1-2.5 ul
...s improved ergonomics for today's exacting laborat...finger rest and the large display windows enhance ...als also feature soft-touch tip ejection with powe... blow-out for 0.2 - 50ul micro volume pipetting. F...
Medicine Products: